J'achète l'étude complète
Synthèse
The global contraceptive market has demonstrated significant growth, with an expected compound annual growth rate (CAGR) of 5.5% for 2027, potentially reaching $30.15 billion by 2027. This expansion is attributed to factors such as demographic growth, increased government initiatives for awareness about unwanted pregnancies and Sexually Transmitted Infections (STIs), as well as changing lifestyles that delay childbearing. The French market follows a similar trend, driven by public awareness of contraception methods and STIs, coupled with investments by sector players in innovative products. Despite the "pill crisis" leading to decreased use of 3rd and 4th generation pills, the pill remains the most used contraceptive method in France. However, the market has seen shifts with increased adoption rates for IUDs and condoms post-crisis. France stands out in Europe for having relatively easy access to contraception, with a score of 90.1% for contraceptive accessibility in 2020. Major players in the global market include Allergan Plc, Bayer AG, and Merck.
Market Analysis: Shifts and Preferences in French Contraceptive Use
The French contraception market, reflecting both global trends and localized preferences, is continuing its growth trajectory, with a notable shift in the methods employed by French women to manage fertility and sexual health. A variety of contraceptive methods are in use, with hormonal pills, intrauterine devices (IUDs), and condoms being the most prevalent. Around a third of women in France opt for contraceptive pills, while a quarter utilizes IUDs and about 16% prefer condoms. Implants and combined pill and condom usage each account for 5% of the methods chosen. Interestingly, the market witnessed a so-called "pill crisis", with significant public and regulatory scrutiny focused on 3rd and 4th generation contraceptive pills due to their associated health risks. This controversy led to a decline in pill usage from around 41% to 32%, with no significant rise in women forgoing contraception altogether. Instead, there was a notable increase in the adoption of IUDs and condoms, suggesting a shift towards perceived safer and more convenient contraceptive options.
The French contraception market was valued at roughly between 330 and 335 million euros, and with an anticipated compounded annual growth rate (CAGR) of approximately 8.07%, it can be estimated to have approached 420 million euros in 2019. This growth is attributed to a heightened awareness of contraceptive methods and sexual health, continued innovation in the sector, and government initiatives promoting access and responsible family planning.
Globally, the market is even more dynamic, with a value of roughly between 22 and 23 billion US dollars , and an expected increase of about 23.3% in labor force participation over a five-year period. With an estimated CAGR of 5.5% for 2027, worldwide contraceptive market revenues are projected to achieve around 30 billion US dollars by 2027. Factors such as demographic growth, changes in lifestyle, and increased educational and career opportunities for women have contributed to this uptrend. The global preference for contraceptive methods varies, with female sterilization, male condoms, and IUDs being the most common choices. In France, contraceptive usage preferences shift with age: women between 15 to 34 years favor the pill, while those aged 35 to 49 prefer IUDs.
Key Contraceptive Market Players: A Snapshot of Industry Leaders
In the dynamic landscape of contraceptive solutions, several key players stand out for their innovation, product offerings, and specialization in various segments of the market.
Bayer AG: Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. In the contraceptive market, Bayer has positioned itself as a specialist in the 3rd and 4th generation of contraceptive pills with popular products like Mélodia, Mélane, and Jasmine. They are also known for their intrauterine devices (IUDs) and had an impactful presence in the emergency contraception segment with the product EllaOne.
- Reckitt Benckiser Group (Durex): Reckitt Benckiser's Durex brand is a household name in sexual health, famously dominating the condom segment. With an impressive market share, Durex has created a wide range of condoms and is recognized for prioritizing safety, comfort, and pleasure.
- LifeStyles Healthcare (Manix, Skyn): Known for their Manix and Skyn brands, LifeStyles Healthcare has carved out significant market share in the sexual well-being and condom market. Their products are often hailed for innovative designs and materials, like the non-latex Skyn range that offers a natural feel.
- MSD France (Merck): With a broad portfolio that includes various healthcare products, MSD France is notable in the contraceptive market for its pill and emergency contraception options. They market an array of contraceptives under different brand names while promoting women's sexual health and well-being.
- Effik: An Italy-based company that has made its mark in the French contraceptive market, mainly in oral contraceptives. Effik has a variety of generic alternatives to more well-known brands, making contraception more accessible and affordable to a broader audience.
- 7 Med Industrie and CCD: These French companies have established a strong foothold mainly in the intrauterine device (IUD) segment. They focus on offering effective and long-lasting contraceptive solutions through their IUDs, which are highly regarded for safety and efficacy.
- HRA Pharma: Another leading company in the emergency contraception sector, HRA Pharma is the creator of the well-known Norlevo morning-after pill. Their products are often at the forefront of over-the-counter emergency contraceptive solutions and are known for their ease of use and accessibility.
- Theramex: Is a dedicated women's healthcare company.
à la compréhension de ce marché
Détail du contenu
Informations
- Nombre de pages : 30 pages
- Format : Version digitale et PDF
- Dernière mise à jour : 27/05/2021
Sommaire et extraits
1 Market overview
1.1 Definition and scope of the study
Contraception refers to all the methods used by men or women in order to make sexual intercourse infertile .
While the contraceptive pill remains the primary contraceptive method in France, there are many other means of contraception, of local or general action and of varying effectiveness and constraints :
- Locally acting methods (avoids pregnancy at the time of intercourse): male or female condom, spermicide, diaphragm, cervical cap
- Hormonal methods hormonally active substances of the estrogen or progestin type (pill, implant, injection, vaginal ring, patch, hormonal intrauterine device)
- Surgical methods definitive methods by laparoscopic or hysteroscopic route in women and by scrotal route in men.
- Natural Methods Methods that do not use external elements to regulate fertility (observation of the woman's menstrual cycle, Ogino method, calendar method, withdrawal method, etc.).
- Male Methods Thermal male contraception method by artificial cryptorchidism, the male pill
- After a report emergency contraception (morning-after pill, two-day pill and copper intrauterine device).
The global contraceptive market was worth 22.49 billion in 2019 The number of employees is expected to increase by 23.3% in 5 years, compared to 2014. This turnover is expected to grow at a CAGR (compound annual growth rate) of 5.5% between 2019 and 2027. This upward trend in sales is mainly due to demographic growth, rising standards of development and living standards, the generalisation of studies and the increasing place of women in the labour market, which is accompanied by a mutiplication of maternity deferrals
The french market of contraception is also progressing. This growth is mainly driven by the growing awareness of the French population to contraceptive methods and sexually transmitted infections (STIs), the player investments of the sector to develop innovative products and government initiatives supporting improved access to contraception and information on contraceptive solutions and Family Planning.
In France, the pill is still the first method used despite the "pill crisis" at the end of 2012. The intrauterine system (IUD or IUD) and the condom are used by respectively 25% and 16% french women.
Liste des graphiques
- Répartition des méthodes de contraception utilisées
- Évolution des méthodes de contraception utilisées
- Raisons d'arrêt de la pilule
- Marché français des dispositifs contraceptifs
- Prévisions de croissance sur le marché mondial de la contraception
Toutes nos études sont disponible en ligne et en PDF
Nous vous proposons de consulter un exemple de notre travail d'étude sur un autre marché !
Entreprises citées dans cette étude
Cette étude contient un panorama complet des entreprises du marché avec les derniers chiffres et actualités de chaque entreprise :
Choisir cette étude c'est :
Accéder à plus de 35 heures de travail
Nos études sont le résultat de plus de 35 heures de recherches et d'analyses. Utiliser nos études vous permet de consacrer plus de temps et de valeur ajoutée à vos projets.
Profiter de 6 années d'expérience et de plus de 1500 études sectorielles déjà produites
Notre expertise nous permet de produire des études complètes dans tous les secteurs, y compris des marchés de niche ou naissants.
Notre savoir-faire et notre méthodologie nous permet de produire des études avec un rapport qualité-prix unique
Accéder à plusieurs milliers d'articles et données payantes
Businesscoot a accès à l'ensemble de la presse économique payante ainsi qu'à des bases de données exclusives pour réaliser ses études de marché (+ 30 000 articles et sources privées).
Afin d'enrichir nos études, nos analystes utilisent également des indicateurs web (semrush, trends…) pour identifier les tendances sur un marché et les stratégies des entreprises. (Consulter nos sources payantes)
Un accompagnement garanti après votre achat
Une équipe dédiée au service après-vente, pour vous garantir un niveau de satisfaction élevé. (+33) 9 70 46 55 00
Un format digital pensé pour nos utilisateurs
Vous accédez à un PDF mais aussi à une version digitale pensée pour nos clients. Cette version vous permet d’accéder aux sources, aux données au format Excel et aux graphiques. Le contenu de l'étude peut ainsi être facilement récupéré et adapté pour vos supports.
Nos offres :
the contraceptive market | France
- Quels sont les chiffres sur la taille et la croissance du marché ?
- Quels leviers tirent la croissance du marché et leur évolution ?
- Quel est le positionnement des entreprises sur la chaine de valeur ?
- Comment se différencient les entreprises du marché ?
- Données issues de plusieurs dizaines de bases de données
Pack 5 études (-15%) France
- 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
- Conservez -15% sur les études supplémentaires achetées
- Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)
Consultez les conditions du pack et de remboursement des crédits non consommés.
Nos références clients
Ils ont consulté nos études
Découvrir les avis (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & Cas clients
Toutes les interviews et cas clients (45)
